Publications by authors named "Jonathan Loree"

Claim this Profile
C
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.
Jeanne Tie, Yuxuan Wang, Jonathan M Loree, Joshua D Cohen, Rachel Wong

Nat Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An asynchronous electronic consent for improving consent in research among patients with cancer.
Brendan J Chia, Joao Paulo Solar Vasconcelos, Daniela Hegebarth, Sophie Chuang, Gale Ladua, Jonathan M Loree

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual PET Imaging with [Ga]Ga-DOTA-TOC and [F]FDG to Localize Neuroendocrine Tumors of Unknown Origin.
Ali Zaidi, Pavithraa Ravi, Ingrid Bloise, Sara Harsini, Heather C Stuart, Jonathan M Loree

Curr Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deep Learning Framework for Classification of Neuroendocrine Neoplasm Whole Slide Images.
Amir Hadjifaradji, Michael Diaz-Stewart, Jenny Chu, David Farnell, David Schaeffer, Jonathan M Loree

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma.
James T Topham, Joanna M Karasinska, Andrew Metcalfe, Hassan A Ali, Steve E Kalloger, Jonathan M Loree

iScience· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada.
John M Hutchinson, Yibing Ruan, Brendan J Chia, Carl J Brown, Robert J Hilsden, Jonathan M Loree

JAMA Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer.
Monish Ahluwalia, Ambica Parmar, Jonathan M Loree, Christopher J O'Callaghan, Dongsheng Tu

Value Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the Economic and Health Impact of Lowering the Recommended Colorectal Cancer Screening Age in Canada Using Fecal Immunochemical Test versus Colonoscopy.
Brendan J Chia, Yibing Ruan, Carl J Brown, Robert J Hilsden, John M Hutchinson, Jonathan M Loree

Cancer Epidemiol Biomarkers Prev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications.
Kathleen Wee, Kevin C Yang, David F Schaeffer, Chen Zhou, Emily Leung, Jonathan M Loree

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete response after neoadjuvant therapy for locally advanced rectal cancer in a real-world setting: a population-based study.
Lina Cadili, Jonathan M Loree, Michael Peacock, Kimberly DeVries, Amandeep Ghuman

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes of lenvatinib therapy for advanced neuroendocrine neoplasms.
Joao Paulo Solar Vasconcelos, Jose Eduardo Nunez Rodriguez, Ali Zaidi, Tharani Krishnan, Helia Jafari, Jonathan M Loree

Endocr Relat Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental healthcare utilisation among individuals with colorectal cancer: population-based cohort studies.
Vicki Cheng, Eric C Sayre, Vienna Cheng, Jonathan M Loree, Sharlene Gill

BMJ Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Versus Six Months of Adjuvant Oxaliplatin-Containing Chemotherapy for Patients With Stage III Colorectal Cancer: A Contemporary Real-World Analysis.
Tharani Krishnan, Emily Leung, Joao Paulo Solar Vasconcelos, Howard Lim, Jonathan M Loree

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.
Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss, Robert J Vanner, David F Schaeffer, Jonathan M Loree

Cancer Res Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol.
Analisa Jia, Lisa Kuramoto, Amir Khakban, Weng Sut Sio, Anthony Traboulsee, Jonathan Loree

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs.
Jonathan M Loree, David Chan, Jennifer Lim, Heather Stuart, Nicolas Fidelman

JAMA Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
Lucy X Ma, Emma Titmuss, Jonathan M Loree, Derek J Jonker, Hagen F Kennecke

J Immunother Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott, Erin B Kennedy, Jordan Berlin, Gina Brown, Myriam Chalabi, Jonathan M Loree

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental health in people living with and beyond colorectal cancer: A patient-oriented constructivist grounded theory.
Vicki Cheng, Helen McTaggart-Cowan, Jonathan M Loree, Rachel A Murphy, Mikaela Barnes

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Jonathan M Loree, Emma Titmuss, James T Topham, Hagen F Kennecke, Harriet Feilotter

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic Profiling of Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of Mutations in Neo--Wildtype Metastatic Colorectal Cancer Is Transient.
Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Jonathan M Loree

JCO Precis Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Akie Watanabe, Sabrina Rai, Lily Yip, Carl J Brown, Jonathan M Loree

World J Surg Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis.
Victoria A Baronas, Arif A Arif, Eric Bhang, Gale K Ladua, Carl J Brown, Jonathan M Loree

Curr Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.
Joao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, Dongsheng Tu, Stephanie Y Brule, Jonathan M Loree

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 Pandemic on Access to Cancer Surgery: Analysis of Surgical Wait Times in British Columbia, Canada.
Delaram Shojaei, Brendan Bakos, Jonathan Loree, Allison Mah, Alan So

Disaster Med Public Health Prep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis